Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

LH · Labcorp Holdings Inc.

$306.96 -4.40% Sep 10 close
Detected setup Wyckoff SOS · Setup Score 51/100

Stand aside — setup invalidated

Setup score 51, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about LH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$LH

Labcorp Holdings Inc.

Labcorp Holdings Inc. is a large-cap Medical/Nursing Services company in the Health Services sector with a market cap of $25B.

Health Services Medical/Nursing Services stock Stage 2 · Advancing Base 2 Scan vol↑ 1.8×
$306.96 latest close
Verdict · setup score 51/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 51, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

Next earnings Monday, October 26, 2026 Report time not confirmed by the source

Deterministic evidence

LH-4.40%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. LH was -3.85 points vs XLV. -3.80 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-4.40% From the open-4.25% Range position10% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $306.96 -4.4% Sep 10 close
52W High $341.80 10.2% below high
Wks Since High 1w
Base Depth 10.6%
RS Rank 33 percentile of scan
SMA 50 $308.97
Avg Vol 691,803
Rel Vol (Sep 10) 1.82×
More stats
52W Low $244.52
Tight Wks 0
Base B2
SMA 200 $276.43
RS Line vs High -8.9%
RS Line Slope -2.3% ▼
Group Rank #41/58
ADR% 2.3%
ATR(14) $7.45 (2.4%)
Vol Pace (live) N/A
U/D Vol 0.67
A/D Days 13A / 15D
A/D Rating D
VDU Bars 0/10 d
Earnings in 44d
Position in 52-week range 64thpercentile of the 52-week range
$244.52low
$341.80high

LH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for LH.

Create Free Account

Technical Analysis Report Card

$LH · $306.96 · as of 2026-09-10 · multi-factor read
43
/ 100
Technicals 43/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$308.97 ↓
100-day$285.11 ↑
200-day$276.43 ↑
Bullish (50 > 200)

RSI (14)

Reading35.5 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateWeakening
Histogram-3.968

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-18% · 9.8%

Piercing the lower band — capitulation or strong selling.

Volume · Buyer vs Seller

Up/Down vol0.67 · Distribution
Rel volume1.82×

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $341.8052-week high
Price · $306.96now
S · $261.81swing level
S · $253.05swing level
S · $249.30swing level

Fibonacci · Uptrend swing

23.6%$319.80
38.2% ◄ price here$306.19
50.0%$295.19
61.8%$284.20
78.6%$268.54

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for LH — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishVolume distribution
Want this read in a legend's voice? Ask a Legend about LH
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D

Trend-template read: fails Price > 50-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $306.96, MA150 $281.26, MA200 $276.43
1.2 150-day MA > 200-day MAMA150 $281.26 vs MA200 $276.43
Failing evidence
1.5 Price > 50-day MAPrice $306.96 vs MA50 $308.97
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 42
7/13 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high10.2% below high | RS line new high: False
S: Volume ≥ 40% above average on breakoutVolume ratio 1.82x
Failing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade D
L: RS rank ≥ 80 (IBD leadership)RS rank 42
3/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $306.96 vs MA200 $276.43
Failing evidence
Relative strength ≥ 60RS 42
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$306.96
Volume vs average1.82x
Failing evidence
Relative strengthRS 42
5/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$306.96
Volume vs average1.82x
Failing evidence
Relative strengthRS 42
5/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$306.96
Volume vs average1.82x
Failing evidence
Relative strengthRS 42
5/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
97RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -2 D
A: 14 D: 16 Net: -265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +7%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 42
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -10.2%

Method Playbook

Trade it like Livermore EXACT LEVELS · PRO
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Wyckoff SOS Historical replay: +20% before −8% within 40 sessions: 27% (n=71) · source bars 2025-03-17–2026-09-04 · avg +4.1% per setup (+0.52R) ⚠ Extended past buy zone ⚠ Not actionable yet
51 setup score
RS Score 42
Trend template 5/8
CANSLIM 51.9* (D)
range low: 253.104 range high: 277.183 range pct: 0.095 sos thrust: 0.107 sos vol ratio: 1.982 sos bars ago: 0 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup? D+W Confluence
Wyckoff SOS · schematic

SOS: breakout above range_high=277.18, thrust=10.7%, vol=2.0x avg, lps=extended, 0 bars ago | Moderate trend (5/8) | High-confidence pattern (70%) | Volume surging | Stage 2 | Readiness 53/100 (early) | CANSLIM 51.9 (D) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

3/7 universals met
  • A relative-strength leader — not met RS rank 33 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Clear of earnings — met in 44 days
  • In a confirmed uptrend — met Stage 2 · Trend template 5/8
  • Volume confirms — met 1.8× average
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $306.96 vs SMA150 $281.26 / SMA200 $276.43
SMA 150 above SMA 200 SMA150 $281.26 vs SMA200 $276.43
SMA 200 trending up Slope +6.85 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $308.97
Price above SMA 50 $306.96 vs SMA50 $308.97
30%+ above 52-week low +25.5% from $244.52
Within 25% of 52-week high -10.2% from $341.80
RS score above 70 RS 42

Fundamentals

52W Range
64%
Mkt Cap SEC
24.9B
Rev YoY
+7%
EPS TTM
$10.46
P/E TTM
29.3x
Float
81M

Company

Company profile
Labcorp Holdings Inc.
LH · NYSE · Health Services · Medical/Nursing Services
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
D 51.9* CANSLIM * disqualified on M
C · Curr. EPS
40
A · Annual EPS
64
N · New Highs
40
S · Supply/Demand
100
L · Leader RS
42
I · Inst. Spons.
50
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
78
W. Support
$248.59
W. Resist
$341.80
W. Patterns
Basing
Weekly Structure

Scan History

3× streak
Sep 09: 78 (Trend Only)Sep 09: 80 (Trend Only)Sep 09: 81 (Trend Only)Sep 10: 55 (Wyckoff SOS)Sep 11: 51 (Wyckoff SOS)Sep 11: 55 (Wyckoff SOS)55
Sep 11
Wyckoff SOS ✓ Gate
55
Sep 11
Wyckoff SOS
51
Sep 10
Wyckoff SOS ✓ Gate
55 0.0%
Sep 09
Trend Only ✓ Gate
81 -4.4%
Sep 09
Trend Only ✓ Gate
80 -4.4%
Sep 09
Trend Only ✓ Gate
78 -4.4%

Get the full picture on LH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial